DiaMedica Therapeutics Inc.
DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX tria…
Government Awards Analysis Beta
It's important to keep an eye on government contracts, because they can make up a substantial portion
of total sales for your researched company.
The Data for the government spending analysis is directly sourced from the
US gov. application interface.
Obligations Over-Time
DiaMedica Therapeutics Inc. has no obligation with a government/award agency.
Latest Obligations
Spending By Type
DiaMedica Therapeutics Inc. can't present spending by time.
Get PRO Today
With PRO you will unlock all insights related to government awards of DiaMedica Therapeutics Inc..